Allergan To Acquire Zeltiq

Allergan has entered into an agreement to acquire Zeltiq Aesthetics, maker of the CoolSculpting system, for roughly $2.475 billion. The sale is expected to close in the second half of 2017. “The acquisition of Zeltiq is highly complementary and strategic to Allergan. By adding the best-in-class body contouring CoolSculpting System to our best-in-class facial aesthetics, plastic surgery and regenerative medicine offerings we are creating a world-class aesthetics business,” said Brent Saunders, chairman and CEO of Allergan.